Daniel F. Voytas Sells 4,666 Shares of Calyxt (CLXT) Stock

Calyxt (NASDAQ:CLXT) insider Daniel F. Voytas sold 4,666 shares of Calyxt stock in a transaction that occurred on Monday, May 21st. The stock was sold at an average price of $16.63, for a total transaction of $77,595.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Daniel F. Voytas also recently made the following trade(s):

  • On Tuesday, May 8th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The stock was sold at an average price of $15.58, for a total transaction of $63,613.14.
  • On Friday, April 20th, Daniel F. Voytas sold 4,666 shares of Calyxt stock. The stock was sold at an average price of $16.87, for a total transaction of $78,715.42.
  • On Monday, April 9th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The stock was sold at an average price of $14.38, for a total transaction of $58,713.54.

CLXT stock traded up $0.77 during trading on Friday, reaching $17.74. The company had a trading volume of 3,297 shares, compared to its average volume of 138,938. The stock has a market capitalization of $479.15 million and a PE ratio of -15.15. The company has a quick ratio of 17.79, a current ratio of 17.79 and a debt-to-equity ratio of 0.27. Calyxt has a twelve month low of $9.26 and a twelve month high of $31.89.

Calyxt (NASDAQ:CLXT) last released its earnings results on Monday, May 7th. The company reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.13. The company had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.20 million. Calyxt had a negative net margin of 5,930.60% and a negative return on equity of 60.81%. equities research analysts expect that Calyxt will post -1.2 earnings per share for the current year.

A number of brokerages have recently issued reports on CLXT. ValuEngine raised shares of Calyxt from a “sell” rating to a “hold” rating in a research report on Wednesday, March 14th. Jefferies Group reaffirmed a “buy” rating and issued a $27.00 price objective on shares of Calyxt in a research report on Thursday, March 1st. Finally, Zacks Investment Research downgraded shares of Calyxt from a “hold” rating to a “sell” rating in a research report on Friday, March 23rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $29.05.

A number of hedge funds have recently added to or reduced their stakes in CLXT. California State Teachers Retirement System acquired a new stake in Calyxt in the 3rd quarter worth approximately $323,000. Goldman Sachs Group Inc. acquired a new stake in Calyxt in the 4th quarter worth approximately $330,000. Schwab Charles Investment Management Inc. acquired a new stake in Calyxt in the 3rd quarter worth approximately $358,000. Deutsche Bank AG boosted its stake in Calyxt by 151.3% in the 4th quarter. Deutsche Bank AG now owns 18,378 shares of the company’s stock worth $404,000 after purchasing an additional 11,064 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its stake in Calyxt by 23.6% in the 1st quarter. Wells Fargo & Company MN now owns 38,048 shares of the company’s stock worth $500,000 after purchasing an additional 7,260 shares in the last quarter. Institutional investors own 21.78% of the company’s stock.

Calyxt Company Profile

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply